Natural Killer Cell Immune Synapse
自然杀伤细胞免疫突触
基本信息
- 批准号:6706321
- 负责人:
- 金额:$ 40.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-03-01 至 2006-02-28
- 项目状态:已结题
- 来源:
- 关键词:MHC class I antigenWiskott Aldrich syndromeactinsantigen presenting cellbiological signal transductioncell cell interactioncellular immunityclone cellsconfocal scanning microscopycytotoxicitydigital imagingenzyme activityexocytosisfluorescence resonance energy transfergene mutationhuman tissuelaboratory mouseleukocyte activation /transformationmutantnatural killer cellsphosphatidylinositol 3 kinasepolymerizationprotein kinase Csynapses
项目摘要
DESCRIPTION (provided by the applicant): The overall objective for these
studies is to gain insight on the molecular events that occur at the single
cell level when natural killer (NK) cells interact with cytolytically
susceptible and non-susceptible target cells. The intercellular contact area,
called the immune synapse (IS), undergoes temporal and spatial changes that are
thought to be of critical importance for optimizing the cellular interactions
and control the outcome. Most studies of the IS have been performed with helper
T-cells interacting with antigen-presenting cells (APC). Formation of the
helper T-cell/APC IS (ThIS) demonstrates a tightly regulated process involving
sequential recruitment of signaling molecules to compartmentalized areas within
the intercellular contact site. The long-term goal for our proposed studies is
to test the hypothesis that the IS formed during cytolytic NK cell interactions
with target cells (NKIS) display important differences from the ThIS that
develops during initiation of clonal T cell proliferation. We will in the
present proposal utilize the MHC class I regulated NK cell cytotoxicity model
for analysis of the cytolytic and non-cytolytic NKIS. We demonstrate in our
preliminary results that these events are associated with the formation of both
a cytolytic NKIS and a non-cytolytic NKIS. We hypothesize that a distinct
subset of signal transduction molecules will be recruited to the cytolytic
NKIS. Specifically, we expect to identify differential recruitment of signaling
molecules that mediate granule exocytosis while enzymes and adaptor molecules
engaged in cell proliferation will be absent from the synapse or displaced away
from active signaling components. We also hypothesize that the inhibitory NK
receptors with ligand specificity for MHC class I molecules regulate the
signaling pathways by ligand-induced movements in the synaptic region. Finally,
we hypothesize that polymerization of actin-cytoskeleton mediated by the
Wiskott-Aldrich Syndrome Protein (WASP) is not an essential component in
mediating the cytotoxic effector events by NK cells. The proposal has three
specific aims: (1) To characterize the MHC class I regulated temporal and
spatial organization of signal transduction molecules in the synaptic region of
NK cells in non-cytolytic and cytolytic interactions with target cells. (2) To
characterize the temporal and spatial organization of NK receptors and their
HLA ligands in the contact region of NK cell-target cell conjugates in
cytolytic and non-cytolytic combinations. (3) To characterize the temporal and
spatial organization of the cytolytic and non-cytolytic NKIS in patients with
different mutations in the WASP gene. We expect these studies to provide new
insight on how NK cells interact with target cells and how MHC class I
molecules regulate these processes.
描述(由申请人提供):总体目标
研究的目的是深入了解发生在单个细胞中的分子事件,
当自然杀伤(NK)细胞与细胞溶解性
易感和非易感靶细胞。细胞间接触面积,
称为免疫突触(IS),经历时间和空间变化,
被认为是至关重要的优化细胞相互作用
并控制结果大多数IS的研究都是在助手的帮助下进行的
与抗原呈递细胞(APC)相互作用的T细胞。形成
辅助性T细胞/APC IS(ThIS)展示了一个严格调节的过程,
将信号分子连续募集到
细胞间的接触点我们拟议研究的长期目标是
为了检验IS在溶细胞NK细胞相互作用期间形成的假设,
与靶细胞(NKIS)显示出与ThIS的重要差异,
在克隆T细胞增殖的起始期间发展。我们会在
本发明利用MHC I类调节的NK细胞细胞毒性模型
用于分析溶细胞和非溶细胞NKIS。我们展示了我们的
初步结果表明,这些事件都与形成
溶细胞NKIS和非溶细胞NKIS。我们假设一种独特的
信号转导分子的子集将被募集到细胞溶解性细胞中。
NKIS。具体地说,我们希望确定不同的招聘信号
介导颗粒胞吐作用的分子,而酶和衔接分子
参与细胞增殖的细胞将从突触中消失或被取代
从活跃的信号组件。我们还假设抑制性NK细胞
对MHC I类分子具有配体特异性的受体调节
通过配体诱导的突触区域运动的信号通路。最后,
我们推测,肌动蛋白介导的细胞骨架聚合,
Wiskott-Aldrich综合征蛋白(WASP)不是糖尿病的必需组分。
通过NK细胞介导细胞毒性效应物事件。该提案有三个
具体目的:(1)描述MHC I类调节的时间和
突触区信号转导分子的空间组织
NK细胞与靶细胞的非溶细胞和溶细胞相互作用。(2)到
表征NK受体的时间和空间组织及其
NK细胞-靶细胞偶联物接触区的HLA配体
溶细胞和非溶细胞组合。(3)为了描述时间和
患者中溶细胞和非溶细胞NKIS的空间组织
WASP基因的不同突变我们希望这些研究能提供新的
关于NK细胞如何与靶细胞相互作用以及MHC I类分子如何相互作用的见解
分子调节这些过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bo Dupont其他文献
Bo Dupont的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bo Dupont', 18)}}的其他基金
NK RECEPTOR FUNCTION IN HAEMATOPOIETIC STEM CELL TRANSPLANTATION
造血干细胞移植中的 NK 受体功能
- 批准号:
7318389 - 财政年份:2007
- 资助金额:
$ 40.75万 - 项目类别:
GENETICS OF NK CELL RECEPTORS AND HLA LIGANDS
NK 细胞受体和 HLA 配体的遗传学
- 批准号:
7318394 - 财政年份:2007
- 资助金额:
$ 40.75万 - 项目类别:
NK RECEPTOR FOR HLA CLASS I IN MARROW TRANSPLANTATION
骨髓移植中 HLA I 类的 NK 受体
- 批准号:
6336332 - 财政年份:2000
- 资助金额:
$ 40.75万 - 项目类别:
NK RECEPTOR FOR HLA CLASS I IN MARROW TRANSPLANTATION
骨髓移植中 HLA I 类的 NK 受体
- 批准号:
6203038 - 财政年份:1999
- 资助金额:
$ 40.75万 - 项目类别:
NK RECEPTOR FOR HLA CLASS I IN MARROW TRANSPLANTATION
骨髓移植中 HLA I 类的 NK 受体
- 批准号:
6102007 - 财政年份:1998
- 资助金额:
$ 40.75万 - 项目类别:
GENETICS OF NK CELL RECEPTORS AND HLA LIGANDS
NK 细胞受体和 HLA 配体的遗传学
- 批准号:
8245885 - 财政年份:1998
- 资助金额:
$ 40.75万 - 项目类别:
NK RECEPTOR FUNCTION IN HAEMATOPOIETIC STEM CELL TRANSPLANTATION
造血干细胞移植中的 NK 受体功能
- 批准号:
8245880 - 财政年份:1998
- 资助金额:
$ 40.75万 - 项目类别:
相似海外基金
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T celllymphomas
T 细胞淋巴瘤发生过程中的 Wiskott-Aldrich 综合征蛋白 (WASp) 信号传导
- 批准号:
10071043 - 财政年份:2020
- 资助金额:
$ 40.75万 - 项目类别:
Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome
Wiskott-Aldrich 综合征中 R 环介导的基因组不稳定性的机制
- 批准号:
10333324 - 财政年份:2020
- 资助金额:
$ 40.75万 - 项目类别:
Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome
Wiskott-Aldrich 综合征中 R 环介导的基因组不稳定性的机制
- 批准号:
10576354 - 财政年份:2020
- 资助金额:
$ 40.75万 - 项目类别:
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
T 细胞淋巴瘤发生过程中的 Wiskott-Aldrich 综合征蛋白 (WASp) 信号传导
- 批准号:
9751816 - 财政年份:2017
- 资助金额:
$ 40.75万 - 项目类别:
Studies necessary to establish ideal HSC gene therapy for Wiskott Aldrich Syndrome
建立 Wiskott Aldrich 综合征理想 HSC 基因疗法所需的研究
- 批准号:
17H04225 - 财政年份:2017
- 资助金额:
$ 40.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Phase 1 Study of Interleukin-2 in Wiskott-Aldrich Syndrome
Interleukin-2 在 Wiskott-Aldrich 综合征中的 1 期研究
- 批准号:
8415338 - 财政年份:2013
- 资助金额:
$ 40.75万 - 项目类别:
Innate vs Adaptive Contributions to Th2 Pathology in Wiskott Aldrich Syndrome
先天与适应性对 Wiskott Aldrich 综合征 Th2 病理学的影响
- 批准号:
8316162 - 财政年份:2011
- 资助金额:
$ 40.75万 - 项目类别:
Innate vs Adaptive Contributions to Th2 Pathology in Wiskott Aldrich Syndrome
先天与适应性对 Wiskott Aldrich 综合征 Th2 病理学的影响
- 批准号:
8119202 - 财政年份:2011
- 资助金额:
$ 40.75万 - 项目类别:
Development of gene therapy for wiskott-aldrich syndrome (WAS)
威斯科特-奥尔德里奇综合征 (WAS) 基因疗法的开发
- 批准号:
7784215 - 财政年份:2010
- 资助金额:
$ 40.75万 - 项目类别:
Molecular immunological analysis of the pathogenesis of Wiskott Aldrich syndrome associated IgA nephropathy
Wiskott Aldrich综合征相关IgA肾病发病机制的分子免疫学分析
- 批准号:
21790972 - 财政年份:2009
- 资助金额:
$ 40.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




